AC Immune SA (ACIU) Reaches $9.01 Formed H&S; Perceptive Advisors Boosted Abiomed (ABMD) Holding By $30.53 Million

ABIOMED, Inc. (NASDAQ:ABMD) Logo

AC Immune SA (ACIU) formed H&S with $8.29 target or 8.00% below today’s $9.01 share price. AC Immune SA (ACIU) has $516.77M valuation. The stock decreased 6.15% or $0.59 during the last trading session, reaching $9.01. About 47,921 shares traded. AC Immune SA (NASDAQ:ACIU) has declined 3.68% since April 8, 2017 and is downtrending. It has underperformed by 15.23% the S&P500.

Perceptive Advisors Llc increased Abiomed Inc (ABMD) stake by 315.63% reported in 2017Q4 SEC filing. Perceptive Advisors Llc acquired 163,271 shares as Abiomed Inc (ABMD)’s stock rose 49.46%. The Perceptive Advisors Llc holds 215,000 shares with $40.29M value, up from 51,729 last quarter. Abiomed Inc now has $12.67 billion valuation. The stock decreased 2.02% or $5.91 during the last trading session, reaching $286.22. About 335,208 shares traded. ABIOMED, Inc. (NASDAQ:ABMD) has risen 128.67% since April 8, 2017 and is uptrending. It has outperformed by 117.12% the S&P500.

Among 14 analysts covering Abiomed (NASDAQ:ABMD), 11 have Buy rating, 0 Sell and 3 Hold. Therefore 79% are positive. Abiomed had 33 analyst reports since August 4, 2015 according to SRatingsIntel. The stock of ABIOMED, Inc. (NASDAQ:ABMD) has “Hold” rating given on Wednesday, August 5 by Piper Jaffray. As per Thursday, February 1, the company rating was maintained by Jefferies. Jefferies maintained the shares of ABMD in report on Thursday, June 29 with “Buy” rating. Piper Jaffray maintained the shares of ABMD in report on Thursday, January 4 with “Buy” rating. Morgan Stanley maintained the shares of ABMD in report on Friday, February 2 with “Equal-Weight” rating. As per Thursday, February 1, the company rating was maintained by Piper Jaffray. The rating was maintained by Leerink Swann with “Outperform” on Wednesday, May 4. The stock of ABIOMED, Inc. (NASDAQ:ABMD) earned “Buy” rating by Stephens on Friday, February 2. The firm has “Buy” rating given on Friday, February 16 by SunTrust. Jefferies maintained ABIOMED, Inc. (NASDAQ:ABMD) rating on Tuesday, June 6. Jefferies has “Buy” rating and $14000 target.

Perceptive Advisors Llc decreased Corbus Pharmaceuticals Hldgs stake by 214,684 shares to 200,000 valued at $1.42M in 2017Q4. It also reduced Marinus Pharmaceuticals Inc (NASDAQ:MRNS) stake by 544,968 shares and now owns 907,732 shares. Tesaro Inc (NASDAQ:TSRO) was reduced too.

Since February 20, 2018, it had 0 insider buys, and 1 insider sale for $5.41 million activity. Shares for $5.41M were sold by Greenfield Andrew J on Tuesday, February 20.

Investors sentiment decreased to 1.18 in 2017 Q4. Its down 0.12, from 1.3 in 2017Q3. It dropped, as 19 investors sold ABMD shares while 110 reduced holdings. 55 funds opened positions while 97 raised stakes. 36.44 million shares or 5.39% less from 38.51 million shares in 2017Q3 were reported. Weaver C Barksdale And Assoc Inc owns 0% invested in ABIOMED, Inc. (NASDAQ:ABMD) for 15 shares. Atlantic Lc owns 104,167 shares or 0.08% of their US portfolio. Maryland-based Proshare Advsrs Ltd Llc has invested 0.01% in ABIOMED, Inc. (NASDAQ:ABMD). New York-based Fred Alger Mngmt has invested 0.42% in ABIOMED, Inc. (NASDAQ:ABMD). De Burlo Group Inc invested in 49,450 shares. Tirschwell Loewy Inc has invested 2.13% in ABIOMED, Inc. (NASDAQ:ABMD). Jane Street Grp Ltd Llc stated it has 3,305 shares or 0% of all its holdings. Arcadia Corporation Mi has invested 0.03% in ABIOMED, Inc. (NASDAQ:ABMD). Alyeska Investment Group Inc Ltd Partnership holds 0.13% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD) for 82,551 shares. Amp Ltd stated it has 15,299 shares. 23,241 are owned by Hamilton Lane Advsrs. Quantbot Techs LP invested 0.08% of its portfolio in ABIOMED, Inc. (NASDAQ:ABMD). Rmb Mngmt Lc reported 37,338 shares. Advsrs Asset Mgmt invested 0.06% in ABIOMED, Inc. (NASDAQ:ABMD). Moreover, Rhenman & Ptnrs Asset Management has 2.19% invested in ABIOMED, Inc. (NASDAQ:ABMD).

ABIOMED, Inc. (NASDAQ:ABMD) Institutional Positions Chart